Media formats available:
Recommended
- CME/CE
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
0.50 creditsJavier Cortes, MD, PhD
Komal Jhaveri, MD, FACP
- FDA Drug Information Updates
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
- Medical Breakthroughs from Penn Medicine
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Shira Johnson, MD
Robert Vonderheide, MD
- Medical Breakthroughs from Penn Medicine
A Thoracic Surgeon's Viewpoint on Screening, Diagnosis and Treatment of a Lung Cancer Patient
Matt Birnholz, MD
Taine Pechet, MD